Kleiner Perkins-backed Elcelyx says its reformulated metformin worked in a PhIIb diabetes study
A little over a year ago San Diego-based Elcelyx Therapeutics raised a $40 million E round to prove in a Phase IIb study that it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
